These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6138036

  • 41. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G, Yamaji Y, Nagai M, Natsumeda Y, Jayaram HN, Zhen WN, Paulik E.
    Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
    [Abstract] [Full Text] [Related]

  • 42. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors.
    Franchetti P, Cappellacci L, Perlini P, Jayaram HN, Butler A, Schneider BP, Collart FR, Huberman E, Grifantini M.
    J Med Chem; 1998 May 07; 41(10):1702-7. PubMed ID: 9572896
    [Abstract] [Full Text] [Related]

  • 43. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase.
    Gharehbaghi K, Grünberger W, Jayaram HN.
    Curr Med Chem; 2002 Apr 07; 9(7):743-8. PubMed ID: 11966437
    [Abstract] [Full Text] [Related]

  • 44. Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
    Weber G, Yamaji Y, Olah E, Natsumeda Y, Jayaram HN, Lapis E, Zhen WN, Prajda N, Hoffman R, Tricot GJ.
    Adv Enzyme Regul; 1989 Apr 07; 28():335-56. PubMed ID: 2576178
    [Abstract] [Full Text] [Related]

  • 45. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
    Jayaram HN, Murayama K, Pillwein K, Zhen W, Weber G.
    Cancer Chemother Pharmacol; 1992 Apr 07; 31(2):93-6. PubMed ID: 1451238
    [Abstract] [Full Text] [Related]

  • 46. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA, Sartorelli AC.
    Mol Pharmacol; 1985 Dec 07; 28(6):567-73. PubMed ID: 2867464
    [Abstract] [Full Text] [Related]

  • 47. Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.
    Micha JP, Kucera PR, Preve CU, Rettenmaier MA, Stratton JA, DiSaia PJ.
    Gynecol Oncol; 1985 Jul 07; 21(3):351-5. PubMed ID: 4007612
    [Abstract] [Full Text] [Related]

  • 48. Critical issues in chemotherapy with tiazofurin.
    Weber G.
    Adv Enzyme Regul; 1989 Jul 07; 29():75-95. PubMed ID: 2699155
    [Abstract] [Full Text] [Related]

  • 49. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
    Pankiewicz KW, Watanabe KA, Lesiak-Watanabe K, Goldstein BM, Jayaram HN.
    Curr Med Chem; 2002 Apr 07; 9(7):733-41. PubMed ID: 11966436
    [Abstract] [Full Text] [Related]

  • 50. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN, Cooney DA, Grusch M, Krupitza G.
    Curr Med Chem; 1999 Jul 07; 6(7):561-74. PubMed ID: 10390601
    [Abstract] [Full Text] [Related]

  • 51. Toxicity and efficacy of benzamide riboside in cancer chemotherapy models.
    Jayaram HN, Yalowitz JA, Arguello F, Greene JF.
    Curr Med Chem; 2002 Apr 07; 9(7):787-92. PubMed ID: 11966443
    [Abstract] [Full Text] [Related]

  • 52. The cytotoxicity and mode of action of 2,3,4-trisubstituted pyrroles and related derivatives in human Tmolt4 leukemia cells.
    Gupton JT, Burham BS, Byrd BD, Krumpe KE, Stokes C, Shuford J, Winkle S, Webb T, Warren AE, Barnes CR, Henry J, Hall IH.
    Pharmazie; 1999 Sep 07; 54(9):691-7. PubMed ID: 10522273
    [Abstract] [Full Text] [Related]

  • 53. Synergistic action of tiazofurin and retinoic acid on differentiation and colony formation of HL-60 leukemia cells.
    Yamaji Y, Natsumeda Y, Yamada Y, Irino S, Weber G.
    Life Sci; 1990 Sep 07; 46(6):435-42. PubMed ID: 1968220
    [Abstract] [Full Text] [Related]

  • 54. Synthesis and biological activity of nucleosides and nucleotides related to the antitumor agent 2-beta-D-ribofuranosylthiazole-4-carboxamide.
    Srivastava PC, Revankar GR, Robins RK.
    J Med Chem; 1984 Mar 07; 27(3):266-9. PubMed ID: 6699872
    [Abstract] [Full Text] [Related]

  • 55. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R.
    Indian J Biochem Biophys; 1989 Jun 07; 26(3):160-5. PubMed ID: 2620910
    [Abstract] [Full Text] [Related]

  • 56. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
    Jurd L, Narayanan VL, Paull KD.
    J Med Chem; 1987 Oct 07; 30(10):1752-6. PubMed ID: 2821258
    [Abstract] [Full Text] [Related]

  • 57. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN, Zhen W, Gharehbaghi K.
    Cancer Res; 1993 May 15; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [Abstract] [Full Text] [Related]

  • 58. Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin.
    Li H, Hallows WH, Punzi JS, Marquez VE, Carrell HL, Pankiewicz KW, Watanabe KA, Goldstein BM.
    Biochemistry; 1994 Jan 11; 33(1):23-32. PubMed ID: 8286346
    [Abstract] [Full Text] [Related]

  • 59. Tiazofurin: molecular and clinical action.
    Weber G, Prajda N, Abonyi M, Look KY, Tricot G.
    Anticancer Res; 1996 Jan 11; 16(6A):3313-22. PubMed ID: 9042306
    [Abstract] [Full Text] [Related]

  • 60. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP.
    Cancer Treat Rep; 1980 Jan 11; 64(4-5):727-9. PubMed ID: 6448690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.